Miraf, diagnosed 2007
Tandem Mobi System

with Control-IQ+ technology

Uses CGM values to predict and help prevent highs and lows

target icon

Day 1 Improvements

Study participants saw a 13% time in range improvement within the first 24 hours.1

Note: Study was conducted using the t:slim X2 insulin pump with Control-IQ technology and Dexcom G6 CGM sensor.

Dashboard of mobile app
Choose How to Wear Tandem Mobi

The pump is so small that it can be worn almost anywhere,* giving you more options for comfort and wearability than ever before.

adhesive sleeve icon
Wear it

Wear it on-body with an adhesive sleeve (sold separately), which is compatible with all infusion sets, including the AutoSoft XC with 5‑inch tubing.

t:slim X2 pump case icon
Clip it

Clip it easily to your clothes, dress, workout gear, or pajamas. Tandem Mobi can be worn almost anywhere.*

pocket icon
Slip it

The impressively small Tandem Mobi is so discreet that you can simply slip it into the coin pocket of your jeans (yes, it’s that small).

infusion sets icon
Disconnect.
Reconnect.
It’s a snap!

Itʼs easy to temporarily disconnect an infusion set from your Tandem Mobi for showering, hot tubs, or contact sports.

Tandem Mobi - Average user pays less than $2/day
Tandem Diabetes Care

#1 in Overall Satisfaction by Healthcare Providers

You may be able to experience the life-changing benefits of Tandem automated insulin delivery for $0 out of pocket.

Seagrove Partners HCP Perspectives (Devices), September 2025 Insulin Delivery Section N=120.

Cost per day calculation reflects the average monthly out-of-pocket cost for pump and disposables necessary to utilize Tandem pump therapy over the life of the 48-month pump warranty. Assumes consumption of 10 infusion sets and cartridges per month.

$0 out of pocket claim based on direct orders from Tandem customers with commercial insurance from 1/1/2025-12/31/2025. Data on file. Actual cost may vary and is subject to individual insurance coverage.

Tandem Mobi

See How Easy
Control Can Be

97% of clinical study participants said Control-IQ+ technology is easy to use.2

Note: Study was conducted using the t:slim X2 insulin pump with Control-IQ technology and Dexcom G6 CGM sensor.

79%

Time in Range

with no increase in hypoglycemia3†

Get Started Today!

With the insulin pump that predicts and helps prevent highs and lows.

sleep icon

Wake Up and Do What Moves You

Control-IQ+ technology includes a dedicated Sleep Activity that uses a narrower and lower range of treatment values to help guard against lows and highs while sleeping.

Anna, diagnosed 2020
Mobile app Dashboard with Glucose Values
mobile app icon

Diabetes Management that’s Convenient and Discreet

The Tandem Mobi system is controllable with a compatible, personal iPhone,‡ offering next-level convenience and discretion.

Tandem Mobi with Multi-Functional Pump Button
plus icon
Life is Better with Options

CGM Sensors

The Tandem Mobi System integrates with Dexcom G7 CGM Systems.†

Infusion Sets

The system is compatible with all Tandem infusion sets, so you can choose the length, angle, and material that best fits your lifestyle.

Izzy (diagnosed 2016) and Dersane (diagnosed 2011)
plus icon
Direct to Watch

When you pair Tandem Mobi with a Dexcom G7 CGM System, you can see your readings on your Apple Watch and bolus from your pump — without having your phone with you.^

checkmark icon

Maintain control and time in range on the go

checkmark icon

Leave your phone behind — one less thing to worry about

checkmark icon

Have greater peace of mind

Learn More
Sameer, diagnosed 2008, with Apple Watch

Ready to order the Tandem Mobi system?

* Tested at 8 feet for 2 hours (IP28 rating).
† CGM sold separately.
The Dexcom G7 15 Day is indicated for ages 18+ and the Dexcom G7 is indicated for ages 2+.

Note: Some studies were conducted using the t:slim X2 insulin pump with Control-IQ technology and Dexcom G6.

References

1. Seagrove Partners HCP Perspectives (Devices), September 2025 Insulin Delivery Section N=120

2. Akturk HK, et al. Diabetes Technol Ther. 2022;24(10):779-783. 

3. Breton MD, Kovatchev BP. Diabetes Technol Ther. 2021;23(9):601-608.

4. As of June, 2026. Data on file, Tandem Diabetes Care.

Important Safety Information

Always read the label and follow the instructions: tandemdiabetes.com/safetyinfo

Important Safety Information

RX ONLY.

Indications for Use

Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient use. The pump is indicated for use in individuals 2 years of age and greater.

Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The Tandem Mobi system with Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater. Control-IQ+ technology is intended for single patient use. Control-IQ+ technology is indicated for use with NovoLog or Humalog U-100 insulin.

Warning: Control-IQ+ technology should not be used by anyone under the age of 2 years old. It should also not be used in patients who require less than 5 units of insulin per day or who weigh less than 20 pounds.

Control-IQ+ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ+ technology if using hydroxyurea. Users of the Tandem Mobi pump and Control-IQ+ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. If your CGM readings do not match your symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. The Tandem Mobi pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit tandemdiabetes.com/safetyinfo for additional important safety information.